Access cutting-edge hypertension and obesity treatment through this clinical trial at a research site in Waterbury. Study-provided care at no cost to qualified participants.
Access hypertension and obesity specialists in Waterbury at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertension and obesity treatment provided free
GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Sponsor: Eli Lilly and Company
Check if you qualify for this hypertension and obesity clinical trial in Waterbury, CT
If you're searching for hypertension and obesity treatment options in Waterbury, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Waterbury research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertension and obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.